BEAT | HeartBeam, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	2.4122 - 2.6500
52 Week Range	1.0600 - 3.39
Beta	1.29
Implied Volatility	14.36%
IV Rank	1.95%
Day's Volume	44,792
Average Volume	68,707
Shares Outstanding	26,562,110
Market Cap	64,545,927
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2021-11-11

Valuation
Profitability
Growth
Health
P/E Ratio	-4.34
Forward P/E Ratio	N/A
EPS	-0.56
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	15
Country	USA
Website	BEAT

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

BEAT's peers: FOXO, EUDA, UTRS, NUTX, HCTI, BFRG, MGRX, LIFW, HLTH, MPLN, WORX

*Chart delayed

Analyzing fundamentals for BEAT we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see BEAT Fundamentals page.

Watching at BEAT technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on BEAT Technicals page.